These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 15576986

  • 1. [The role of insulin receptor substrates in bone metabolism].
    Akune T.
    Clin Calcium; 2004 Feb; 14(2):289-92. PubMed ID: 15576986
    [Abstract] [Full Text] [Related]

  • 2. [Involvement of insulin and IGF-1 signaling molecules in bone metabolism].
    Ogata N, Kawaguchi H.
    Clin Calcium; 2008 May; 18(5):614-22. PubMed ID: 18445879
    [Abstract] [Full Text] [Related]

  • 3. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.
    Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H.
    J Clin Invest; 2000 Apr; 105(7):935-43. PubMed ID: 10749573
    [Abstract] [Full Text] [Related]

  • 4. [Hormones and osteoporosis update. Insulin/IGF-I and bone].
    Kawaguchi H.
    Clin Calcium; 2009 Jul; 19(7):1015-25. PubMed ID: 19568000
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice.
    Yamaguchi M, Ogata N, Shinoda Y, Akune T, Kamekura S, Terauchi Y, Kadowaki T, Hoshi K, Chung UI, Nakamura K, Kawaguchi H.
    Endocrinology; 2005 Jun; 146(6):2620-8. PubMed ID: 15718274
    [Abstract] [Full Text] [Related]

  • 7. Deficiency of insulin receptor substrate-1 impairs skeletal growth through early closure of epiphyseal cartilage.
    Hoshi K, Ogata N, Shimoaka T, Terauchi Y, Kadowaki T, Kenmotsu S, Chung UI, Ozawa H, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2004 Feb; 19(2):214-23. PubMed ID: 14969391
    [Abstract] [Full Text] [Related]

  • 8. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells.
    Hennige AM, Ozcan U, Okada T, Jhala US, Schubert M, White MF, Kulkarni RN.
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066
    [Abstract] [Full Text] [Related]

  • 9. Decreased lactation capacity and altered milk composition in insulin receptor substrate null mice is associated with decreased maternal body mass and reduced insulin-dependent phosphorylation of mammary Akt.
    Hadsell DL, Olea W, Lawrence N, George J, Torres D, Kadowaki T, Lee AV.
    J Endocrinol; 2007 Aug; 194(2):327-36. PubMed ID: 17641282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination.
    Freude S, Leeser U, Müller M, Hettich MM, Udelhoven M, Schilbach K, Tobe K, Kadowaki T, Köhler C, Schröder H, Krone W, Brüning JC, Schubert M.
    J Neurochem; 2008 Nov; 107(4):907-17. PubMed ID: 18717815
    [Abstract] [Full Text] [Related]

  • 12. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
    Sun H, Tu X, Liu M, Baserga R.
    J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
    [Abstract] [Full Text] [Related]

  • 13. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
    Sharfi H, Eldar-Finkelman H.
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
    [Abstract] [Full Text] [Related]

  • 14. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts CT.
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [Abstract] [Full Text] [Related]

  • 15. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings.
    Bartke A.
    Aging Cell; 2008 Jun; 7(3):285-90. PubMed ID: 18346217
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.
    Sadagurski M, Yakar S, Weingarten G, Holzenberger M, Rhodes CJ, Breitkreutz D, Leroith D, Wertheimer E.
    Mol Cell Biol; 2006 Apr; 26(7):2675-87. PubMed ID: 16537911
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like effects of visfatin on human osteoblasts.
    Xie H, Tang SY, Luo XH, Huang J, Cui RR, Yuan LQ, Zhou HD, Wu XP, Liao EY.
    Calcif Tissue Int; 2007 Mar; 80(3):201-10. PubMed ID: 17340225
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH, Lee AV.
    Cancer Res; 2006 May 15; 66(10):5304-13. PubMed ID: 16707456
    [Abstract] [Full Text] [Related]

  • 19. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
    Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Enjoji M, Takayanagi R, Nakamuta M.
    Int J Mol Med; 2008 Apr 15; 21(4):507-11. PubMed ID: 18360697
    [Abstract] [Full Text] [Related]

  • 20. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?
    Di Paolo S, Teutonico A, Leogrande D, Capobianco C, Schena PF.
    J Am Soc Nephrol; 2006 Aug 15; 17(8):2236-44. PubMed ID: 16807405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.